Alpha 2.0
Login Register
» Articles » PMID: 13678864

Candesartan and Heart Failure: the Allure of CHARM

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2003 Sep 19
PMID 13678864
Citations 4
Authors
Harvey D White
Affiliations
Soon will be listed here.
Citing Articles

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Rosendorff C, Lackland D, Allison M, Aronow W, Black H, Blumenthal R Circulation. 2015; 131(19):e435-70.

PMID: 25829340 PMC: 8365343. DOI: 10.1161/CIR.0000000000000207.

Angiotensin II receptor antagonists (AT-blockers, ARBs, sartans): similarities and differences.

van Zwieten P Neth Heart J. 2015; 14(11):381-387.

PMID: 25696573 PMC: 2557311.

Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.

Colombo G, Caruggi M, Ottolini C, Maggioni A Vasc Health Risk Manag. 2008; 4(1):223-34.

PMID: 18629370 PMC: 2464765. DOI: 10.2147/vhrm.2008.04.01.223.

Hypertension in the elderly: a Japanese perspective.

Ogihara T, Rakugi H Drugs Aging. 2005; 22(4):297-314.

PMID: 15839719 DOI: 10.2165/00002512-200522040-00003.